Article info
Abstracts Accepted for Publication
Spondyloarthritis - treatment
AB0742 Intravenous Loading and Subcutaneous Maintenance with Secukinumab Provides Sustained Improvement in Multiple Measures of Disease Activity in Subjects with Active Ankylosing Spondylitis: 52-Week Data From the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Measure 1 Study
Citation
AB0742 Intravenous Loading and Subcutaneous Maintenance with Secukinumab Provides Sustained Improvement in Multiple Measures of Disease Activity in Subjects with Active Ankylosing Spondylitis: 52-Week Data From the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Measure 1 Study
Publication history
- First published June 9, 2015.
Online issue publication
February 13, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions